ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

MIRA MIRA Pharmaceuticals Inc

0.9868
0.1368 (16.09%)
May 21 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
MIRA Pharmaceuticals Inc MIRA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.1368 16.09% 0.9868 18:03:08
Open Price Low Price High Price Close Price Previous Close
0.88 0.771 1.04 1.02 0.85
more quote information »

Recent News

Date Time Source Heading
5/21/202407:45PRNUSMIRA Pharmaceuticals in Discussions with Memorial Sloan..
5/20/202407:00PRNUSMira Pharmaceuticals Advances Preclinical Trials Towards an..
5/13/202415:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
4/02/202407:00PRNUSMira Pharmaceuticals Announces Encouraging Preclinical..
3/21/202410:04PRNUSMIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head..
3/07/202415:45EDGAR2Form 8-K - Current report
2/05/202407:30PRNUSMIRA Pharmaceuticals Provides Corporate Update
1/17/202415:30EDGAR2Form 8-K - Current report
12/27/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
12/27/202316:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/27/202316:27EDGAR2Form SC 13D/A - General statement of acquisition of..
12/18/202315:50EDGAR2Form S-1 - General form for registration of securities under..
12/04/202307:00PRNUSMIRA Pharmaceuticals Releases Breakthrough Data from..
12/01/202316:00EDGAR2Form 8-K - Current report
11/29/202307:00PRNUSMIRA Pharmaceuticals Announces Ketamir-2's Oral..
11/21/202309:42PRNUSMIRA Pharmaceuticals To Host Shareholder Update Call on..
11/21/202309:09PRNUSMIRA Pharmaceuticals Announces Paradigm-Shift in Cognitive..
11/20/202315:18EDGAR2Form SC 13D/A - General statement of acquisition of..
11/20/202315:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/20/202307:10EDGAR2Form 8-K - Current report
11/20/202307:00PRNUSMIRA Pharmaceuticals Announces Exclusive Licensing Agreement..
9/18/202307:30PRNUSMIRA Pharmaceuticals Shows its Prescription Pill More..
9/05/202307:31PRNUSMIRA Pharmaceuticals and MZ Group Partner to Strengthen..
8/31/202307:31PRNUSMIRA Pharmaceuticals to Participate in 6th Annual..
8/29/202310:39PRNUSMIRA Pharmaceuticals to Host Virtual Roadshow Webinar on..

Your Recent History

Delayed Upgrade Clock